Raily Aesthetic Medicine International Holdings Past Earnings Performance
Past criteria checks 0/6
Raily Aesthetic Medicine International Holdings's earnings have been declining at an average annual rate of -64.1%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 0.2% per year.
Key information
-64.1%
Earnings growth rate
-63.0%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 0.2% |
| Return on equity | -24.4% |
| Net Margin | -15.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected
Feb 07Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing
Dec 19Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected
Aug 22Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are
Sep 17Revenue & Expenses Breakdown
How Raily Aesthetic Medicine International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 209 | -32 | 95 | 2 |
| 31 Mar 24 | 199 | -32 | 94 | 2 |
| 31 Dec 23 | 189 | -32 | 92 | 2 |
| 30 Sep 23 | 179 | -26 | 88 | 2 |
| 30 Jun 23 | 168 | -20 | 84 | 2 |
| 31 Mar 23 | 166 | -18 | 84 | 2 |
| 31 Dec 22 | 165 | -16 | 85 | 2 |
| 30 Sep 22 | 178 | -13 | 88 | 1 |
| 30 Jun 22 | 191 | -11 | 90 | 0 |
| 31 Mar 22 | 190 | -14 | 90 | 0 |
| 31 Dec 21 | 188 | -18 | 89 | 0 |
| 30 Sep 21 | 193 | -3 | 83 | 0 |
| 30 Jun 21 | 197 | 11 | 77 | 0 |
| 31 Mar 21 | 181 | 8 | 73 | 0 |
| 31 Dec 20 | 165 | 4 | 70 | 0 |
| 30 Sep 20 | 161 | 0 | 70 | 0 |
| 30 Jun 20 | 158 | -4 | 69 | 0 |
| 31 Mar 20 | 174 | 3 | 69 | 0 |
| 31 Dec 19 | 191 | 10 | 68 | 0 |
| 31 Dec 18 | 159 | 18 | 63 | 0 |
| 31 Dec 17 | 113 | 17 | 49 | 0 |
Quality Earnings: 2135 is currently unprofitable.
Growing Profit Margin: 2135 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2135 is unprofitable, and losses have increased over the past 5 years at a rate of 64.1% per year.
Accelerating Growth: Unable to compare 2135's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2135 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).
Return on Equity
High ROE: 2135 has a negative Return on Equity (-24.36%), as it is currently unprofitable.